ChIP-on-chip analysis revealed increased histone activation modifications (H3K4me3 and K3K9/14Ac) at the SYK promoter, whereas the histone repression marker (H3k9me3) was unchanged in human retinoblastoma in situ xenografts and cell lines (71). The gene discussed is SYK; the disease is retinoblastoma.